← Back to Cibo Flash
Earnings

Haixi Pharma (02637) announced interim results

  • RevenueRMB3.1bn
  • Net profitRMB81.0M
  • Profit attributable to ownersRMB81.0M
  • Revenue YoY+3.8%
  • Net profit YoY-24.8%
  • Depreciation & amortisationHK$7.7M
  • Capital expenditureHK$-44.9M
  • Interest-bearing debtHK$83.3M

Source Haixi Pharma

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect